New England Journal of Medicine Q1 Unclaimed
The New England Journal of Medicine (NEJM) is the world’s leading medical journal and website. Published continuously for over 200 years, NEJM delivers high-quality, peer-reviewed research and interactive clinical content to physicians, educators, and the global medical community. Our mission is to bring physicians the best research and information at the intersection of biomedical science and clinical practice and to present this information in understandable and clinically useful formats It has an SJR impact factor of 26,015.
New England Journal of Medicine focuses its scope in these topics and keywords: patients, treatment, care, therapy, virus, chronic, medical, trial, coronary, primary, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
0 €
Inmediate OA- €
Embargoed OA- €
Non OAMetrics
26,015
SJR Impact factor1130
H Index1410
Total Docs (Last Year)4561
Total Docs (3 years)14396
Total Refs133956
Total Cites (3 years)1854
Citable Docs (3 years)33.93
Cites/Doc (2 years)10.21
Ref/DocOther journals with similar parameters
Annual Review of Public Health Q1
Annual Review of Pathology: Mechanisms of Disease Q1
The Lancet Global Health Q1
Annual Review of Clinical Psychology Q1
JAMA - Journal of the American Medical Association Q1
Compare this journals
Aims and Scope
Best articles by citations
Clinical Characteristics of Coronavirus Disease 2019 in China
A Novel Coronavirus from Patients with Pneumonia in China, 2019
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
17774 Citations View moreRadiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
12869 Citations View moreImproved Survival with Ipilimumab in Patients with Metastatic Melanoma
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Sorafenib in Advanced Hepatocellular Carcinoma
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome
8717 Citations View moreUse of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
Intensive Insulin Therapy in Critically Ill Patients
Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
If you are a journal editor you can claim the journal profile and add new information for the visitors.
Comments